IPAR Biotechnology was founded in 2001, on the bases of research breakthroughs of scientific work on natural medicine. As a rising transnational high tech biomedical company along the ancient Silk Road, IPAR brings its technological and personnel advantage into the field and implements unique product, brand, and market management strategy. IPAR initiated Central Asia development strategy and in just a few years, the company established its core competitive edge, obtained rapid growth. Today, IPAR has developed into a strong transnational enterprise operating across biotechnology, health management, and e-commerce.

Now the platform IPAR has built serves many independent business managers speaking 9 different languages from over 10 countries, helping many families live quality life, bringing them health, happiness, friendship as well as prosperity. At the same time, they are free to spend their time and energy, large or small, to achieve the goals they put up and live more decent life.

Since 2008 IPAR has started implementing second five- year development plan, and successfully established China - Kyrgyzstan - Russia - Turkey products supply chain project. Completed two transnational GMP standard factory projects, 1000 acres of medicinal plan cultivation demonstration base, GMP pharmaceutical packaging materials production base and test center, completed IPAR Pharmaceuticals company share structure reform, optimized business model and finished the entire ecommerce network and laid a solid foundation for the next "global R & D - international supply chain" plan.